Back to KROS
CITADEL ADVISORS LLC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
11
Latest value
$1.9M
Q3 2026
Peak value
$3.1M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $2.6M |
| Q1 2026 | $190K |
| Q1 2026 | $1.9M |
| Q1 2026 | $1.4M |
| Q2 2026 | $3.1M |
| Q2 2026 | $1.1M |
| Q2 2026 | $154K |
| Q2 2026 | $3.1M |
| Q2 2026 | $1.1M |
| Q2 2026 | $154K |
| Q3 2026 | $1.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.9M | 162.7K | — | — |
| Q2 2026 | $154K | 14.4K | — | — |
| Q2 2026 | $1.1M | 106.8K | — | — |
| Q2 2026 | $3.1M | 289.3K | — | — |
| Q2 2026 | $154K | 14.4K | — | — |
| Q2 2026 | $1.1M | 106.8K | — | — |
| Q2 2026 | $3.1M | 289.3K | — | — |
| Q1 2026 | $1.4M | 129.9K | — | — |
| Q1 2026 | $1.9M | 174.1K | — | — |
| Q1 2026 | $190K | 17.2K | — | — |
| Q1 2026 | $2.6M | 232.5K | — | — |